Exane Derivatives’s Cooper Companies COO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.82K Sell
36
-216
-86% -$19.1K ﹤0.01% 413
2022
Q1
$26.3K Sell
252
-20
-7% -$2.01K 0.01% 639
2021
Q4
$28.5K Sell
272
-812
-75% -$82.7K 0.01% 553
2021
Q3
$112K Sell
1,084
-328
-23% -$35K 0.03% 507
2021
Q2
$144K Sell
1,412
-580
-29% -$56.8K 0.03% 489
2021
Q1
$191K Sell
1,992
-1,216
-38% -$115K 0.05% 306
2020
Q4
$291K Sell
3,208
-3,052
-49% -$262K 0.09% 249
2020
Q3
$528K Buy
6,260
+148
+2% +$11.4K 0.15% 123
2020
Q2
$433K Buy
6,112
+5,132
+524% +$380K 0.12% 155
2020
Q1
$67.5K Sell
980
-136
-12% -$11.1K 0.02% 329
2019
Q4
$95.9K Hold
1,116
0.02% 320
2019
Q3
$82.8K Buy
+1,116
New +$90K 0.01% 332

Other funds holding COO

Exane Derivatives's COO Position: Q2 2022 in Review

Exane Derivatives reduced its Cooper Companies (COO) stake by 86% in Q2 2022, selling an estimated $19.1K and leaving 36 shares worth $2.82K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Exane Derivatives first reported a position in COO in Q3 2019 and has held it in 12 quarters since. The position peaked at $528K in Q3 2020. 567 funds tracked by Wall St. Rank hold COO as of Q2 2022.

  • Exane Derivatives held 36 shares of Cooper Companies worth $2.82K as of Q2 2022.
  • Exane Derivatives sold 216 Cooper Companies shares in Q2 2022, an estimated $19.1K.
  • Cooper Companies made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #413 holding.
  • Exane Derivatives first reported a position in Cooper Companies in Q3 2019 and has held it in 12 quarters since.
  • Exane Derivatives's Cooper Companies position peaked at $528K in Q3 2020.
  • 567 funds tracked by Wall St. Rank held Cooper Companies as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.